Ixekizumab (Taltz®)
A Contract Award Notice
by THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) ("NSS")
- Source
- Find a Tender
- Type
- Contract (Goods)
- Duration
- not specified
- Value
- £3M
- Sector
- HEALTH
- Published
- 17 May 2021
- Delivery
- not specified
- Deadline
- n/a
Concepts
Location
All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014
Geochart for 1 buyers and 1 suppliers
1 buyer
- NHS National Services Scotland NSS Edinburgh
1 supplier
- Eli Lilly Hampshire
Description
Supply of Ixekizumab (Taltz®) to NHS Scotland.
Total Quantity or Scope
The Authority has awarded this agreement as a single supplier agreement to one (1) supplier.
Award Detail
| 1 | Eli Lilly (Hampshire)
|
Award Criteria
| price | _ |
CPV Codes
- 33600000 - Pharmaceutical products
Legal Justification
Drug is patent protected for the duration of the agreement.
Other Information
** PREVIEW NOTICE, please check Find a Tender for full details. ** The estimated value(s) referred to in Section II.I.7 and section V.2.4 covers the twelve (12) month contract duration and the twelve (12) month extension period of the agreement. (SC Ref:653745)
Reference
- ocds-h6vhtk-02b195
- FTS 010788-2021